By analyzing the data of related patients in the TCGA database and combining it with the ROC curve table (AUG>0.9), we concluded that DNAAF5 is a potential prognostic biomarker and involves the disease pathogenesis for HCC patients (Figure 1D). Here, DNAAF5 is linked to hepatocellular carcinoma.